Weight Loss Drug Belviq Pulled From Market Over ‘slight’ Cancer Risk

The maker of a weight loss drug pulled it from the market Thursday at the request of federal regulators, who said it posed a slight increased risk of cancer. Japan’s Eisai Inc. said it was voluntarily withdrawing the drug, Belviq. (The company’s U.S. headquarters is in Woodcliff Lake, New Jersey.) However, the company said in a statement that it disagreed with the U.S.

Topics:  japan&rsquo   eisai inc   woodcliff lake   jersey    however   u.s food   drug administration s   the fda   type   qysmia   eisai    in   u.s     a   belviq   fda   bmi   pulled   market   slight   cancer   risk   weight loss drug   approved   drugs   patients   heart   participants   increased   pills   problems   roughly   study   produced   time   month   data   drug’s   lost   company   thoughts   agency   benefit   high   contrave   stop   suicidal   people   adults   dummy   safety   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News